CollPlant Biotechnologies (CLGN) EPS (Basic) (2017 - 2026)
CollPlant Biotechnologies' (CLGN) quarterly EPS (Basic) came in at -$0.23 in Q1 2026, down 57.49% YoY from -$0.53 in Q1 2025, and up 91.35% on a QoQ basis from -$2.62 in Q4 2025.
CollPlant Biotechnologies (CLGN) EPS (Basic) (2017 - 2026) Analysis & Trends
CollPlant Biotechnologies (CLGN) has 10 years of EPS (Basic) data on file, last reported at -$0.23 in Q1 2026.
- Quarterly EPS (Basic) fell 57.49% year-over-year to -$0.23 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.81 (down 196.25% YoY) and the FY2025 annual result came in at -$3.27, up 4.57% from the prior year.
- EPS (Basic) improved to -$0.23 in Q1 2026, from -$2.62 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $0.0 in Q2 2023 to a low of -$2.62 in Q4 2025.
- A 5-year average of -$0.29 and a median of $0.0 in 2025 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2022 — EPS (Basic) jumped 230.66% — and 2023, when it slumped 1247706470.58%.
- Tracing CLGN's EPS (Basic) over 5 years: stood at $0.0 in 2022, then slumped by 1247706470.58% to -$0.44 in 2023, then gained by 6.68% to -$0.41 in 2024, then plunged by 536.82% to -$2.62 in 2025, then jumped by 91.35% to -$0.23 in 2026.
- The last three EPS (Basic) figures came in at -$0.23 (Q1 2026), -$2.62 (Q4 2025), and -$0.28 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.23 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.06 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.18 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -0.72 |
| 10 | CollPlant Biotechnologies | 4.13 Mn | 4.13 Mn | -243,000.00 | -0.23 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 30, 2026 | -0.23 |
| Dec 31, 2025 | -2.62 |
| Sep 30, 2025 | -0.28 |
| Jun 30, 2025 | 0.00 |
| Mar 30, 2025 | -0.14 |
| Dec 31, 2024 | -0.41 |
| Sep 30, 2024 | -0.39 |
| Jun 30, 2024 | 0.00 |
| Mar 31, 2024 | 0.00 |
| Dec 31, 2023 | -0.44 |
| Sep 30, 2023 | -0.41 |
| Jun 30, 2023 | 0.00 |
| Mar 31, 2023 | 0.00 |
| Dec 31, 2022 | 0.00 |
| Sep 30, 2022 | 0.00 |
| Jun 30, 2022 | 0.00 |
| Mar 31, 2022 | 0.00 |
| Dec 31, 2021 | 0.00 |
| Sep 30, 2021 | 0.00 |
| Jun 30, 2021 | 0.00 |